XHS vs. IHE
XHS (SPDR S&P Health Care Services ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds - XHS tracks the S&P Health Care Services Select Industry Index while IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index. Both are passively managed. Over the past 10 years, XHS returned 7.46%/yr vs 7.81%/yr for IHE. A 0.61 correlation means they provide meaningful diversification when combined. XHS charges 0.35%/yr vs 0.42%/yr for IHE.
Performance
XHS vs. IHE - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with XHS having a 6.32% return and IHE slightly higher at 6.47%. Both investments have delivered pretty close results over the past 10 years, with XHS having a 7.46% annualized return and IHE not far ahead at 7.81%.
XHS
- 1D
- 0.28%
- 1M
- 2.77%
- YTD
- 6.32%
- 6M
- 5.39%
- 1Y
- 16.58%
- 3Y*
- 8.47%
- 5Y*
- 0.44%
- 10Y*
- 7.46%
IHE
- 1D
- 1.16%
- 1M
- 1.80%
- YTD
- 6.47%
- 6M
- 8.51%
- 1Y
- 40.15%
- 3Y*
- 17.47%
- 5Y*
- 9.98%
- 10Y*
- 7.81%
XHS vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XHS SPDR S&P Health Care Services ETF | 6.32% | 18.83% | 1.76% | 5.15% | -19.87% | 9.76% | 33.66% | 18.81% | 1.96% | 17.65% |
IHE iShares U.S. Pharmaceuticals ETF | 6.47% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
Correlation
The correlation between XHS and IHE is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.36 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.55 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Sep 30, 2011 | 0.61 |
Over the past year, the correlation between XHS and IHE has dropped to 0.36 - well below their long-term average of 0.61, suggesting their price drivers have been diverging.
XHS vs. IHE - Sectors Allocation Comparison
Sectors
XHS
IHE
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XHS
IHE
Financial Services
XHS
IHE
-
Basic Materials
XHS
-
IHE
-
Communication Services
XHS
-
IHE
-
Consumer Cyclical
XHS
-
IHE
-
Consumer Defensive
XHS
-
IHE
-
Energy
XHS
-
IHE
-
Industrials
XHS
-
IHE
-
Real Estate
XHS
-
IHE
-
Technology
XHS
-
IHE
-
Utilities
XHS
-
IHE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XHS vs. IHE — Risk / Return Rank
XHS
IHE
XHS vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Services ETF (XHS) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XHS | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.41 | ||
| Sortino ratioReturn per unit of downside risk | -2.04 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.40 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 1.39 | 4.76 | -3.37 |
| Martin ratioReturn relative to average drawdown | 3.83 | 14.35 | -10.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XHS | IHE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.95 | 2.36 | -1.41 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.02 | 0.62 | -0.60 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.33 | 0.43 | -0.10 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | 0.51 | +0.06 |
Drawdowns
XHS vs. IHE - Drawdown Comparison
The maximum XHS drawdown since its inception was -39.32%, roughly equal to the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for XHS and IHE.
Loading charts...
Drawdown Indicators
| XHS | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.32% | -38.20% | -1.12% |
Max Drawdown (1Y)Largest decline over 1 year | -11.99% | -8.47% | -3.52% |
Max Drawdown (3Y)Largest decline over 3 years | -17.81% | -15.92% | -1.89% |
Max Drawdown (5Y)Largest decline over 5 years | -32.62% | -16.03% | -16.59% |
Max Drawdown (10Y)Largest decline over 10 years | -39.32% | -29.59% | -9.73% |
Current DrawdownCurrent decline from peak | -1.78% | -2.80% | +1.02% |
Average DrawdownAverage peak-to-trough decline | -10.20% | -7.92% | -2.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.33% | 2.81% | +1.52% |
Volatility
XHS vs. IHE - Volatility Comparison
The current volatility for SPDR S&P Health Care Services ETF (XHS) is 4.80%, while iShares U.S. Pharmaceuticals ETF (IHE) has a volatility of 5.53%. This indicates that XHS experiences smaller price fluctuations and is considered to be less risky than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XHS | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.80% | 5.53% | -0.73% |
Volatility (6M)Calculated over the trailing 6-month period | 11.86% | 12.48% | -0.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.56% | 17.07% | +0.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.10% | 16.24% | +4.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.40% | 18.05% | +4.35% |
XHS vs. IHE - Expense Ratio Comparison
XHS has a 0.35% expense ratio, which is lower than IHE's 0.42% expense ratio.
Dividends
XHS vs. IHE - Dividend Comparison
XHS's dividend yield for the trailing twelve months is around 0.25%, less than IHE's 1.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.65% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
XHS SPDR S&P Health Care Services ETF | 0.25% | 0.27% | 0.38% | 0.23% | 0.19% | 0.20% | 0.23% | 2.37% | 0.34% | 0.22% | 0.28% | 0.93% |
Frequently Asked Questions
XHS and IHE have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHE has higher volatility (5.53%) compared to XHS (4.80%). In terms of maximum drawdown, XHS dropped -39.32% vs IHE's -38.20%.
On 10-year performance, IHE leads with 7.81% vs 7.46% for XHS. On fees, XHS is cheaper at 0.35% per year. On volatility, XHS has been the lower-risk option at 4.80%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IHE has performed better with a 7.81% return vs 7.46%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XHS is cheaper with a 0.35% expense ratio, compared with 0.42% for IHE.
IHE has the higher dividend yield at 1.65%, compared with 0.25% for XHS.
XHS tracks S&P Health Care Services Select Industry Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. They also come from different issuers: State Street and iShares. Their fees differ too: 0.35% for XHS and 0.42% for IHE.
IHE currently has the higher Sharpe Ratio (2.36 vs 0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XHS and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer